What it's for (Indications)
- Azelaic acid, topical, is a dicarboxylic acid approved for the treatment of inflammatory and non-inflammatory lesions of mild to moderate acne vulgaris (Acne Vulgaris Guideline, AAD) in adults and adolescents 12 years of age and older.
- It is also indicated for the topical treatment of the inflammatory papules and pustules of mild to moderate rosacea (National Rosacea Society Expert Committee, 2021).
- Its therapeutic efficacy in these conditions stems from its multifaceted mechanism of action, addressing key pathological components such as follicular hyperkeratinization, bacterial proliferation, and inflammation.
- Clinical trials have demonstrated significant reductions in lesion counts and erythema associated with both acne and rosacea, leading to improved dermatological outcomes for patients.
- The selection of azelaic acid is often considered for individuals seeking an alternative to retinoids or antibiotics, or as a complementary therapy due to its generally favorable tolerability profile and effectiveness across diverse skin types.
Dosage Information
| Type | Guideline |
|---|---|
| Standard | For the treatment of acne vulgaris and rosacea, azelaic acid topical is typically applied to the affected skin areas twice daily, in the morning and evening. Available formulations commonly include a 15% gel or foam, and a 20% cream, depending on the specific product and indication. The skin should be thoroughly cleansed with a mild cleanser and patted dry before application. A thin layer of the product should be gently massaged into the entire affected facial area or other affected skin regions, avoiding the eyes, mouth, and other mucous membranes. Hands should be washed immediately after application. The duration of treatment varies based on the severity of the condition and individual patient response; however, clinical improvement usually becomes evident after approximately four weeks of continuous application, with optimal results often achieved after several months of therapy. Interruption or premature cessation of treatment may lead to recurrence of symptoms. Patients should be advised not to exceed the recommended frequency or amount of application, as this does not enhance efficacy and may increase the risk of local skin irritation. |
Safety & Warnings
Common Side Effects
- Topical azelaic acid is generally well-tolerated, but local skin reactions are common, particularly at the initiation of therapy.
- The most frequently reported adverse reactions, occurring in 1-10% of patients, include transient burning, stinging, itching (pruritus), erythema, dryness, peeling (exfoliation), and mild irritation at the application site.
- These local reactions are typically mild to moderate in intensity, often decrease in severity, and tend to resolve with continued use as the skin acclimates to the treatment.
- Less common adverse effects, reported in fewer than 1% of patients, include contact dermatitis, rash, paresthesia (tingling sensation), skin discoloration (hypopigmentation, particularly in darker skin types), and occasional exacerbation of asthma.
- Although rare, more severe hypersensitivity reactions such as angioedema, urticaria, or anaphylaxis have been reported, necessitating immediate discontinuation and medical attention.
- Patients should be counseled on the expected transient irritation and advised to contact their healthcare provider if reactions become severe, persistent, or if signs of a systemic allergic reaction develop.
Serious Warnings
- Black Box Warning: Azelaic acid topical does not carry a formal Black Box Warning issued by the U.S. Food and Drug Administration (FDA) or equivalent regulatory bodies internationally. This typically signifies that the drug does not have exceptionally severe or life-threatening risks that warrant such a prominent warning. However, it is imperative for healthcare professionals and patients to be aware of significant potential serious warnings and precautions associated with its use, even in the absence of a boxed warning. These include the potential for severe local irritation, leading to significant discomfort, burning, stinging, or peeling, which may necessitate treatment modification or discontinuation. Rare but serious hypersensitivity reactions, including angioedema, asthma exacerbation, or severe allergic contact dermatitis, have been reported and require immediate medical attention. Additionally, reversible hypopigmentation has been noted in some individuals, particularly those with darker skin types, and warrants careful monitoring. While not a Black Box Warning, these factors underscore the importance of patient counseling, adherence to application instructions, and prompt reporting of any concerning adverse effects to ensure safe and effective treatment.
- While generally safe, azelaic acid topical requires careful consideration of several warnings to ensure patient safety and optimize treatment outcomes.
- Local irritation, characterized by burning, stinging, itching, or erythema, is common, especially during the initial weeks of therapy.
- If irritation becomes severe or persistent, patients should be advised to reduce the frequency of application to once daily or temporarily discontinue treatment and consult their physician.
- Accidental contact with the eyes, mouth, or other mucous membranes should be meticulously avoided due to potential irritation; if contact occurs, rinse thoroughly with copious amounts of water.
- Hypersensitivity reactions, although rare, including angioedema, asthma exacerbation, or urticaria, have been reported.
- Should any signs of a severe allergic reaction manifest, treatment must be immediately discontinued, and appropriate medical intervention sought.
- Azelaic acid has also been associated with reversible hypopigmentation, particularly in individuals with darker complexions; close monitoring for changes in skin pigmentation is recommended.
- Patients with asthma should be monitored, as rare cases of asthma exacerbation have been linked to azelaic acid.
- It is crucial to use sunscreen and protective clothing during treatment, as sun exposure can exacerbate rosacea and some acne lesions, and while azelaic acid is not typically photosensitizing, general photoprotection is always advisable in dermatological care.
- Pediatric and geriatric patients may require individualized assessment due to potential differences in skin sensitivity.
How it Works (Mechanism of Action)
Azelaic acid exerts its therapeutic effects through a multi-modal mechanism relevant to both acne and rosacea pathogenesis. In acne vulgaris, it exhibits bacteriostatic activity against *Cutibacterium acnes* (formerly *Propionibacterium acnes*) and *Staphylococcus epidermidis* by inhibiting microbial protein synthesis, thereby reducing bacterial colonization within the pilosebaceous unit. Furthermore, azelaic acid normalizes keratinization in the follicular infundibulum, reducing abnormal growth of epidermal cells that line the hair follicle. This action prevents the formation of microcomedones and subsequent follicular occlusion, a primary event in acne development. For rosacea, its primary efficacy is attributed to its anti-inflammatory and antioxidant properties. It reduces the generation of reactive oxygen species (ROS) and inhibits pro-inflammatory cytokines, which contribute to the inflammation and erythema characteristic of rosacea. Azelaic acid also modulates kallikrein-5 activity, an enzyme involved in the inflammatory cascade and epidermal barrier dysfunction observed in rosacea. By addressing these diverse pathological pathways, azelaic acid effectively reduces inflammatory lesions and erythema associated with both conditions, providing a comprehensive therapeutic approach.
Commercial Brands (Alternatives)
No other brands found for this formula.